{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:16:35Z","timestamp":1790223395911,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T00:00:00Z","timestamp":1272499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T00:00:00Z","timestamp":1272499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/leu.2010.66","type":"journal-article","created":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T05:46:36Z","timestamp":1272519996000},"page":"1179-1185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["COX-2-dependent PGE2 acts as a growth factor in mycosis fungoides (MF)"],"prefix":"10.1038","volume":"24","author":[{"given":"K L M","family":"Kopp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C S","family":"Kauczok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Lauenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Krejsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K W","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Wasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Ralfkiaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"\u00d8dum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Woetmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,29]]},"reference":[{"key":"BFleu201066_CR1","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"E Olsen","year":"2007","unstructured":"Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713\u20131722.","journal-title":"Blood"},{"key":"BFleu201066_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000108320","volume":"118","author":"L Karenko","year":"2007","unstructured":"Karenko L, Hahtola S, Ranki A . Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL). Cytogenet Genome Res 2007; 118: 353\u2013361.","journal-title":"Cytogenet Genome Res"},{"key":"BFleu201066_CR3","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385","volume":"88","author":"E Diamandidou","year":"1996","unstructured":"Diamandidou E, Cohen PR, Kurzrock R . Mycosis fungoides and Sezary syndrome. Blood 1996; 88: 2385\u20132409.","journal-title":"Blood"},{"key":"BFleu201066_CR4","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1182\/blood-2005-06-2536","volume":"107","author":"A Sors","year":"2006","unstructured":"Sors A, Jean-Louis F, Pellet C, Laroche L, Dubertret L, Courtois G et al. Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis. Blood 2006; 107: 2354\u20132363.","journal-title":"Blood"},{"key":"BFleu201066_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.plipres.2007.01.001","volume":"46","author":"Y-J Kang","year":"2007","unstructured":"Kang Y-J, Mbonye UR, DeLong C, Wada M, Smith W . Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res 2007; 46: 108\u2013125.","journal-title":"Prog Lipid Res"},{"key":"BFleu201066_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/1-4020-5688-5_4","volume":"42","author":"RE Harris","year":"2007","unstructured":"Harris RE . Cyclooxygenase-2 (COX-2) and the inflammogenesis of cancer. Subcell Biochem 2007; 42: 93\u2013126.","journal-title":"Subcell Biochem"},{"key":"BFleu201066_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1124\/pr.59.3.1","volume":"59","author":"B Samuelsson","year":"2007","unstructured":"Samuelsson B, Morgenstern R, Jakobsson PJ . Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev 2007; 59: 207\u2013224.","journal-title":"Pharmacol Rev"},{"key":"BFleu201066_CR8","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1074\/jbc.R600038200","volume":"282","author":"Y Sugimoto","year":"2007","unstructured":"Sugimoto Y, Narumiya S . Prostaglandin E receptors. J Biol Chem 2007; 282: 11613\u201311617.","journal-title":"J Biol Chem"},{"key":"BFleu201066_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"A Greenhough","year":"2009","unstructured":"Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C et al. The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009; 30: 377\u2013386.","journal-title":"Carcinogenesis"},{"key":"BFleu201066_CR10","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.2174\/138161208785294654","volume":"14","author":"MP Bernard","year":"2008","unstructured":"Bernard MP, Bancos S, Sime PJ, Phipps RP . Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise. Curr Pharm Des 2008; 14: 2051\u20132060.","journal-title":"Curr Pharm Des"},{"key":"BFleu201066_CR11","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.2353\/ajpath.2010.090607","volume":"176","author":"H Katoh","year":"2010","unstructured":"Katoh H, Hosono K, Ito Y, Suzuki T, Ogawa Y, Kubo H et al. COX-2 and prostaglandin EP3\/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems. Am J Pathol 2010; 176: 1469\u20131483.","journal-title":"Am J Pathol"},{"key":"BFleu201066_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","volume":"10","author":"J Cuzick","year":"2009","unstructured":"Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 2009; 10: 501\u2013507.","journal-title":"Lancet Oncol"},{"key":"BFleu201066_CR13","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1182\/blood-2006-04-017863","volume":"109","author":"A Woetmann","year":"2007","unstructured":"Woetmann A, Lovato P, Eriksen KW, Krejsgaard T, Labuda T, Zhang Q et al. Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins. Blood 2007; 109: 3325\u20133332.","journal-title":"Blood"},{"issue":"3 Part 1","key":"BFleu201066_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF02631086","volume":"28A","author":"K Kaltoft","year":"1992","unstructured":"Kaltoft K, Bisballe S, Dyrberg T, Boel E, Rasmussen PB, Thestrup-Pedersen K . Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides. In Vitro Cell Dev Biol 1992; 28A (3 Part 1): 161\u2013167.","journal-title":"In Vitro Cell Dev Biol"},{"key":"BFleu201066_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/ijc.2910490218","volume":"49","author":"G Starkebaum","year":"1991","unstructured":"Starkebaum G, Loughran Jr TP, Waters CA, Ruscetti FW . Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor. Int J Cancer 1991; 49: 246\u2013253.","journal-title":"Int J Cancer"},{"key":"BFleu201066_CR16","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1084\/jem.154.5.1403","volume":"154","author":"JE Gootenberg","year":"1981","unstructured":"Gootenberg JE, Ruscetti FW, Mier JW, Gazdar A, Gallo RC . Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor. J Exp Med 1981; 154: 1403\u20131418.","journal-title":"J Exp Med"},{"key":"BFleu201066_CR17","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1182\/blood-2008-09-181024","volume":"113","author":"T Krejsgaard","year":"2009","unstructured":"Krejsgaard T, Vetter-Kauczok CS, Woetmann A, Kneitz H, Eriksen KW, Lovato P et al. Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma. Blood 2009; 113: 5896\u20135904.","journal-title":"Blood"},{"key":"BFleu201066_CR18","first-page":"365","volume-title":"Methods in Molecular Biology, vol. 132: Bioinformatics Methods and Protocols","author":"S Rozen","year":"2000","unstructured":"Rozen S, Skaletsky HJ . Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds). Methods in Molecular Biology, vol. 132: Bioinformatics Methods and Protocols. Humana Press: Totowa, NJ, 2000. pp 365\u2013386."},{"key":"BFleu201066_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/cyto.990130205","volume":"13","author":"WG Telford","year":"1992","unstructured":"Telford WG, King LE, Fraker PJ . Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry 1992; 13: 137\u2013143.","journal-title":"Cytometry"},{"key":"BFleu201066_CR20","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.cellsig.2008.08.007","volume":"20","author":"WH Faour","year":"2008","unstructured":"Faour WH, Gomi K, Kennedy CRJ . PGE2 induces COX-2 expression in podocytes via the EP4 receptor through a PKA-independent mechanism. Cell Signal 2008; 20: 2156\u20132164.","journal-title":"Cell Signal"},{"key":"BFleu201066_CR21","first-page":"42","volume":"30","author":"L Wang","year":"2008","unstructured":"Wang L, Chen W, Xie X, He Y, Bai X . Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer. Exp Oncol 2008; 30: 42\u201351.","journal-title":"Exp Oncol"},{"key":"BFleu201066_CR22","first-page":"605","volume":"20","author":"Y Du","year":"2008","unstructured":"Du Y, Zhang S, Wang Z, Zhou W, Luan M, Yang X et al. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1. Oncol Rep 2008; 20: 605\u2013611.","journal-title":"Oncol Rep"},{"key":"BFleu201066_CR23","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/S0149-2918(00)80005-3","volume":"21","author":"MM Goldenberg","year":"1999","unstructured":"Goldenberg MM . Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis. Clin Ther 1999; 21: 1497\u20131513; discussion 1427\u20131428.","journal-title":"Clin Ther"},{"key":"BFleu201066_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.bcp.2007.08.029","volume":"75","author":"P Pyrko","year":"2008","unstructured":"Pyrko P, Kardosh A, Sch\u00f6nthal AH . Celecoxib transiently inhibits cellular protein synthesis. Biochem Pharmacol 2008; 75: 395\u2013404.","journal-title":"Biochem Pharmacol"},{"key":"BFleu201066_CR25","doi-asserted-by":"publisher","first-page":"27613","DOI":"10.1074\/jbc.M201119200","volume":"277","author":"S Arico","year":"2002","unstructured":"Arico S, Pattingre S, Bauvy C, Gane P, Barbat A, Codogno P et al. Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line. J Biol Chem 2002; 277: 27613\u201327621.","journal-title":"J Biol Chem"},{"key":"BFleu201066_CR26","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1172\/JCI24826","volume":"115","author":"EJ Kim","year":"2005","unstructured":"Kim EJ, Hess S, Richardson SK, Newton S, Showe LC, Benoit BM et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest 2005; 115: 798\u2013812.","journal-title":"J Clin Invest"},{"key":"BFleu201066_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/157489209788452849","volume":"4","author":"R de Souza Pereira","year":"2009","unstructured":"de Souza Pereira R . Selective cyclooxygenase-2 (COX-2) inhibitors used for preventing or regressing cancer. Recent Pat Anticancer Drug Discov 2009; 4: 157\u2013163.","journal-title":"Recent Pat Anticancer Drug Discov"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201066","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T09:28:42Z","timestamp":1648718922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,29]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["BFleu201066"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.66","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,29]]},"assertion":[{"value":"1 December 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}